Commercial Services and Supplies
Company Overview of American Association For Cancer Research
American Association for Cancer Research is a cancer research organization of over 22,000 laboratories and clinical scientists. The organization prints and publishes scientific journals including Clinical Cancer Research, Molecular Cancer Therapeutics, Molecular Cancer Research, Cancer Epidemiology, and Biomarkers & Prevention. American Association for Cancer Research was founded in 1907 and is based in Philadelphia, Pennsylvania.
615 Chestnut Street
Philadelphia, PA 19106-4404
Founded in 1907
Key Executives for American Association For Cancer Research
Chief Executive Officer and Director
Compensation as of Fiscal Year 2013.
American Association For Cancer Research Key Developments
Stand Up to Cancer, Dutch Cancer Society, American Association for Cancer Research, Hubrecht Institute, University Medical Center Utrecht, Netherlands Cancer Institute, and Wellcome Trust Sanger Institute Announce Formation of Dream Team
Nov 12 13
Stand Up To Cancer (SU2C) and the Dutch Cancer Society (KWF Kankerbestrijding), along with the American Association for Cancer Research (AACR), SU2Cs scientific partner, announced the formation of a Dream Team dedicated to developing new tools and technologies for preclinical drug testing and analysis. The Sta Op Tegen Kanker (Stand Up To Cancer) Dream Team Translational Cancer Research Grant will provide EUR 6 million ($8.1 million, at the current conversion rate) in funding over four years for this project that will establish a novel, genetically diverse living biobank of patients tumor samples that are maintained and grown in a laboratory, using technology developed by this Dream Team. Called tumor organoids, these growing tumors provide an unprecedented opportunity to investigate the DNA changes that have occurred in these tumors and the consequences of those changes. Importantly, these tumor organoids also will allow researchers to conduct studies of sensitivity and resistance to a large number of anticancer drugs in a laboratory, laying the groundwork for more sophisticated clinical trials that will test treatment regimens specific to the genetic profiles of individual patients and their tumors. Researchers on this Dream Team represent four institutions: the Hubrecht Institute, the University Medical Center Utrecht, the Netherlands Cancer Institute, and the Wellcome Trust Sanger Institute. This Dream Team unites researchers across Europe in a concerted effort to use a groundbreaking new technology to rapidly analyze novel treatment modalities. Hans Clevers, M.D., Ph.D., will lead the Dream Team. Johannes Bos, Ph.D., is the co-leader of the project, which is titled Tumor Organoids: A New Preclinical Model for Drug Sensitivity Analysis.
American Association for Cancer Research Appoints Mitchell R. Stoller as Executive Director of AACR Foundation for the Prevention and Cure of Cancer
Jul 22 13
The American Association for Cancer Research (AACR) announced the appointment of Mitchell R. Stoller as executive director of the AACR Foundation for the Prevention and Cure of Cancer. In his role, Stoller will lead strategy and work closely with the AACR Foundation Board of Trustees to manage the development and expansion of fundraising and program activities for the foundation. For 30 years, Stoller has been dedicated to solving complex strategic challenges for a number of nonprofit organizations, including the Nicholas Sparks Foundation, Safe Kids Worldwide, the Marrow Foundation (Be the Match), the Lance Armstrong Foundation (LiveSTRONG), the Christopher Reeve Paralysis Foundation, and the Sudden Infant Death Syndrome Alliance. Stoller currently serves on the board of directors of the LiveSTRONG Foundation and the Players Development Academy. He formerly served on the boards of the Temple Har Shalom, the Ridge Sports Foundation, and the National Health Council.
American Association For Cancer Research Announces Executive Changes
Apr 10 13
American Association For Cancer Research announced its new leadership as Charles L. Sawyers, M.D., became president of the organization for 2013-2014. Sawyers is chair of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center and a Howard Hughes Medical Institute investigator. Frank McCormick, Ph.D., F.R.S., D.Sc. (hon.), served with distinction as the AACR president for the 2012-2013 term and will now fulfill the role of past president for 2013-2014. McCormick is the director of the UCSF Helen Diller Family Comprehensive Cancer Center. Carlos L. Arteaga, M.D., is AACR president-elect for 2013-2014 and will assume the presidency in April 2014. Arteaga is a professor of medicine and cancer biology at Vanderbilt University School of Medicine, in Nashville, Tenn., where he holds the Donna S. Hall chair in breast cancer research. He also serves as associate director for clinical research and director of the Breast Cancer Research Program at Vanderbilt-Ingram Cancer Center.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|